Cardiac Arrest Molecular and Proteomic Study - CAMERA

• Research type

  Research Study

• Full title

  Improving Prediction of Cardiovascular and Neurological Outcomes After Out of Hospital Cardiac Arrest - The Cardiac Arrest Molecular and Proteomic Study (CAMERA)

• IRAS ID

  233828

• Contact name

  Philip MacCarthy

• Contact email

  philipmaccarthy@nhs.net

• Duration of Study in the UK

  2 years, 0 months, 3 days

• Research summary

  This study aims to improve how we care for patients who suffer a medical condition where the heart stops in the community called “cardiac arrest” (Out of Hospital Cardiac Arrest - OOHCA). This study is a prospective study and its purpose is to identify patients admitted with cardiac arrest who are most likely to survive. This could improve how we treat patients with this condition in the future. In particular, our research study may help:
  • Identify novel specific molecular biomarkers to predict cardiovascular outcomes in cardiac arrest patients
  • Develop molecular signatures to predict myocardial dysfunction and patterns of recovery in cardiac arrest patients
  • Improve characterisation of early and late neuro-cognitive outcomes in OOHCA survivors
  • Identify novel MRI brain parameters to predict complex neurocognitive outcomes.

  Patients will be included in the study for 6 months.

• REC name

  London - Bromley Research Ethics Committee

• REC reference

  18/LO/0221

• Date of REC Opinion

  26 Mar 2018

• REC opinion

  Further Information Favourable Opinion